Our Vision, Mission and Core Values

Launched in September 2012, TransCelerate Biopharma Inc. aims to simplify and accelerating the delivery of innovative medicines to patients. With so much progress and so much future opportunity, we have continued to refine our focus. The new statements below reflect our organization’s continued commitment:

Our Vision

To improve the health of people around the world by accelerating and simplifying the research and development of innovative new therapies.

Our Mission

To to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines.

Our Core Values

Transparency & Openness
Trust & Integrity

Learn More

For Sites & Training Providers

Resources for Sites and Training Providers, including common Sponsor forms and criteria for GCP  training that are mutually recognized by TransCelerate Member Companies, are available by clicking the button below.

Learn More

Our Events

TransCelerate executives and members present at many industry conferences and meetings all across the globe.  Click on the button below to see a comprehensive list of these events.

Learn More

Latest News

TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform

Cognizant announced that it has been selected by TransCelerate to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials. Read more here.

Risk-Based Monitoring Update – Volume II

TransCelerate BioPharma Inc. has released the second update to its position paper outlining a methodology for risk-based site monitoring.  The update and related materials can be viewed here.

TransCelerate BioPharma Inc. Launches Two New Global Initiatives, Names Two New Board Members

TransCelerate launched two new global initiatives enabled by broad participation and collaboration across the global research and development (R&D) community: develop a position on the best and most efficient methods for redacting privacy information found in clinical study reports and an approach for the anonymization of patient level data shared with the broader healthcare community; […]